Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04146077 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Active Surveillance for Low Risk Prostate Cancer

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 22, 2021 (before its estimated October 2024 completion). Its status may not reflect the trial's current state.

Record History

  1. Re-verified, no change to tracked fieldsv4
  2. Start date changed from estimate of Oct 2019 to Oct 1, 2019v3
  3. Secondary endpoints: details revised at 1 of 1 entryv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
An active surveillance protocol for patients diagnosed low-risk prostate cancer will be held. We plan to use PSA (prostate-specific antigen) testing, DRE (digital rectal examination), TRUS (transrectal ultrasound), MRI (magnetic resonance imaging) and follow-up biopsies to monitor patients and detect cancer progression in time.
Trial Details
NCT Number NCT04146077
Lead Sponsor I.M. Sechenov First Moscow State Medical University
Collaborators: Moscow Regional Research and Clinical Institute (MONIKI), Pirogov Russian National Research Medical University
Conditions
(from sponsor)		 Prostate Cancer, Prostate Adenocarcinoma
Related terms Prostatic Neoplasms
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov